A combined LSD1-HDAC inhibitor, CORIN, a synthetic hybrid agent derived from the Class I HDAC inhibitor (Entinostat) and an LSD1 inhibitor (tranylcypromine analog), showed much greater growth inhibition of melanoma lines compared to Entinostat alone (26). Here, HDAC9 is linked to melanoma.